Please provide your email address to receive an email when new articles are posted on . Sustained virologic response occurred in 81.8% of patients after the first DAA treatment course. Despite this, ...
In the pre-specified per-protocol population, belapectin showed a statistically significant reduction (p-value 0.05) in development of esophageal varices in 2mg/kg cohort compared to placebo While ...
Measuring liver stiffness using transient elastography can predict severe portal hypertension in patients with hepatitis C-related cirrhosis, according to a new study in the May issue of Hepatology, ...
Galectin Therapeutics, Inc. announced results from its NAVIGATE trial, which evaluated belapectin in patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH) cirrhosis and portal ...
Acquired SEPS are associated with portal hypertension, cirrhosis, and complications of decompensation. In particular, the effects of NVEPS on portal pressure are variable, but there is evidence of ...
Spleen stiffness measurement (SSM) offers a noninvasive method to diagnose portal hypertension in BCR::ABL1-negative MPN patients, potentially improving patient management. SSM captures hepatic ...
Clinical factors associated with variceal hemorrhage have been studied in 240 patients with bleeding varices and compared with 240 nonbleeding patients matched for cirrhosis and degree of ...
A total number of 454 patients were invited to participate in the study. Seventeen patients (3.7 %) resigned from the study (fifteen patients did not want to enter the study, two patients were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results